Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Prinomastat

😃Good
Catalog No. T12539LCas No. 192329-42-3
Alias KB-R9896, AG3340

Prinomastat (AG3340) is an orally active and selective inhibitor of metalloproteinases (MMPs) that crosses the blood-brain barrier.

Prinomastat

Prinomastat

😃Good
Purity: 99.23%
Catalog No. T12539LAlias KB-R9896, AG3340Cas No. 192329-42-3
Prinomastat (AG3340) is an orally active and selective inhibitor of metalloproteinases (MMPs) that crosses the blood-brain barrier.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$67In StockIn Stock
2 mg$119In StockIn Stock
5 mg$252In StockIn Stock
10 mg$455In StockIn Stock
25 mg$733In StockIn Stock
50 mg$987In StockIn Stock
100 mg$1,360In StockIn Stock
200 mg$1,830-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.23%
ee:98.178%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Prinomastat (AG3340) is an orally active and selective inhibitor of metalloproteinases (MMPs) that crosses the blood-brain barrier.
Targets&IC50
MMP1:79 nM, MMP9:5 nM, MMP9:0.26 nM (Ki), MMP2:0.05 nM (Ki), Collagenases 1:0.03 nM (Ki), MMP3:6..3 nM, MMP3:0.3 nM (Ki)
In vitro
In C57MG/Wnt1 cells, Prinomastat (0.1 µg/mL, 1 µg/mL; 4 days) significantly decreases MMP-3 promoter activity[1].
In vivo
In a human fibrosarcoma mouse model (HT1080), Prinomastat (50 mg/kg; intraperitoneal injection) is well tolerated by the animals, and exhibits significant tumor growth inhibition. It has a short half-life of 1.6 hours.
SynonymsKB-R9896, AG3340
Chemical Properties
Molecular Weight423.51
FormulaC18H21N3O5S2
Cas No.192329-42-3
SmilesCC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(Oc2ccncc2)cc1
Relative Density.1.377g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 1 mg/mL (2.36 mM), Sonication is recommended.
H2O: 1 mg/mL (2.36 mM), when pH is adjusted to 3 with HCl. Sonication is recommmended.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM2.3612 mL11.8061 mL23.6122 mL118.0610 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Prinomastat | purchase Prinomastat | Prinomastat cost | order Prinomastat | Prinomastat chemical structure | Prinomastat in vivo | Prinomastat in vitro | Prinomastat formula | Prinomastat molecular weight